FN1 and hepatocellular carcinoma: Lenvatinib indirectly suppresses fibronectin in HCC cells under normoxic condition in vitro, but hypoxia induces transcription factors including HIF-1α, which increase fibronectin expression leading to the lenvatinib resistance in HCC cells under hypoxic conditions [219].